101 related articles for article (PubMed ID: 856442)
1. Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue.
Morfin RF; Leav I; Charles JF; Cavazos LF; Ofner P; Floch HH
Cancer; 1977 Apr; 39(4):1517-34. PubMed ID: 856442
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of testosterone in the human prostate and seminal vesicles.
Kjoseland O; Tveter KJ; Attramadal A; Hansson V; Haugen HN; Mathisen W
Scand J Urol Nephrol; 1977; 11(1):1-6. PubMed ID: 557833
[TBL] [Abstract][Full Text] [Related]
3. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Bard DR; Lasnitzki I
J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
[TBL] [Abstract][Full Text] [Related]
4. The 11β-hydroxyandrostenedione pathway and C11-oxy C
du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2020 Feb; 196():105497. PubMed ID: 31626910
[TBL] [Abstract][Full Text] [Related]
5. C19-steroid metabolism by spontaneous adenocarcinoma of the A X C rat ventral prostate.
Shain SA; Nitchuk WM; McCullough B
J Natl Cancer Inst; 1977 Mar; 58(3):747-52. PubMed ID: 839567
[TBL] [Abstract][Full Text] [Related]
6. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
Morfin RF; Charles JF; Floch HH
J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
[No Abstract] [Full Text] [Related]
7. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
9. [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].
Jacobi GH; Kurth KH; Altwein JE
Urologe A; 1979 Mar; 18(2):91-8. PubMed ID: 433016
[TBL] [Abstract][Full Text] [Related]
10. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
11. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
12. Testosterone metabolism of fibroblasts grown from prostatic carcinoma, benign prostatic hyperplasia and skin fibroblasts.
Schweikert HU; Hein HJ; Romijn JC; Schröder FH
J Urol; 1982 Feb; 127(2):361-7. PubMed ID: 6174738
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
Perel E; Killinger DW
J Steroid Biochem; 1983 Aug; 19(2):1135-9. PubMed ID: 6193342
[TBL] [Abstract][Full Text] [Related]
14. Comparison of testosterone, 5alpha-dihydrotestosterone and 5alpha-adrostane-3beta, 17beta-diol metabolisms in human normal and hyperplastic prostates.
Morfin RF; Di Stefano S; Bercovici JP; Floch HH
J Steroid Biochem; 1978 Mar; 9(3):245-52. PubMed ID: 77360
[No Abstract] [Full Text] [Related]
15. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
16. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
17. Formation of 5alpha-reduced androgens in the testes and urogenital tract of the grey short-tailed opossum, Monodelphis domestica.
Wilson JD; Renfree MB; Auchus RJ; Pask AJ; Shaw G
Reprod Fertil Dev; 2009; 21(5):649-54. PubMed ID: 19486601
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
20. In vitro (7 minus-3H)-testosterone metabolism by the rat ventral prostate effect of some exogenous compounds.
Patwardhan VV; Lanthier A
J Steroid Biochem; 1975 Feb; 6(2):137-41. PubMed ID: 1152461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
